What is he best known for?
The fields of study he is best known for:
The scientist’s investigation covers issues in Antibody, Biosensor, Chromatography, Nanotechnology and Molecular biology.
The concepts of his Antibody study are interwoven with issues in Listeria monocytogenes, Recombinant DNA and Antigen.
His studies deal with areas such as Antibody fragments, Recombinant antibodies, Surface plasmon resonance and Polyclonal antibodies as well as Biosensor.
His study in Chromatography is interdisciplinary in nature, drawing from both Fetuin, Methyl methacrylate and Clopidol.
His Nanotechnology research focuses on subjects like Computational biology, which are linked to Bispecific antibody.
His Molecular biology study combines topics in areas such as Affinity chromatography, Monoclonal antibody, Immobilization procedure and Amine functionalization.
His most cited work include:
- Advances in biosensors for detection of pathogens in food and water (444 citations)
- Studies on Coumarins and Coumarin-Related Compounds to Determine their Therapeutic Role in the Treatment of Cancer (441 citations)
- The Pharmacology, Metabolism, Analysis, and Applications of Coumarin and Coumarin-Related Compounds (414 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Chromatography, Antibody, Biochemistry, Biosensor and Molecular biology.
His work deals with themes such as Immunoassay and Metabolite, which intersect with Chromatography.
His Antibody research is multidisciplinary, incorporating elements of Recombinant DNA and Antigen.
His Biosensor study is associated with Nanotechnology.
His Molecular biology study frequently draws connections to adjacent fields such as Escherichia coli.
His biological study spans a wide range of topics, including High-performance liquid chromatography and Glucuronide.
He most often published in these fields:
- Chromatography (26.50%)
- Antibody (26.78%)
- Biochemistry (18.52%)
What were the highlights of his more recent work (between 2017-2021)?
- Antibody (26.78%)
- Biochemistry (18.52%)
- Nanotechnology (13.11%)
In recent papers he was focusing on the following fields of study:
Richard O'Kennedy mostly deals with Antibody, Biochemistry, Nanotechnology, Microfluidics and Biosensor.
Richard O'Kennedy has researched Antibody in several fields, including Molecular biology, Biological system, Recombinant DNA and Antigen.
His work on Amino acid, Proteolysis and Ligand as part of general Biochemistry study is frequently linked to Stability and Chain, bridging the gap between disciplines.
His studies in Nanotechnology integrate themes in fields like Analyte, Physiological saline and Interdigitated electrode.
His Microfluidics research incorporates elements of Chip and Process engineering.
The study incorporates disciplines such as Chromatography, Competitive immunoassay and Freshwater systems in addition to Biosensor.
Between 2017 and 2021, his most popular works were:
- Developments in Point-of-Care Diagnostic Technology for Cancer Detection (30 citations)
- Ultrasensitive direct impedimetric immunosensor for detection of serum HER2. (29 citations)
- Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer. (20 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Biomarker, Biosensor, Cardiac biomarkers, Point-of-care testing and Troponin I.
His Biomarker research incorporates themes from Cohort study, Prostatectomy, Biochemistry and Monoclonal antibody.
To a larger extent, he studies Nanotechnology with the aim of understanding Biosensor.
His Troponin I study incorporates themes from Electrochemical biosensor, Ultra sensitive and Cardiac troponin.
His research in Analyte intersects with topics in Disease biomarker, Interdigitated electrode, Matrix, Molecularly imprinted polymer and Molecular imprinting.
His Myocardial infarction study combines topics from a wide range of disciplines, such as Point of care and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
